The product is the real deal. I think CYDY has great

New Post Public Reply Private Reply Replies (1) Message Board
jacketsndisney Bw #19630
499
The product is the real deal. I think CYDY has great potential, but I've based my valuations and investment decisions on what I believe Leronlimab is worth not the effectivenes of management. It is hard to see how it doesn't get approved for combo HIV by FDA at this point. They just need to get the BLA submitted and get the clock ticking towards approval. That will set the company on the path to credibility.

That is what is so frustrating about the BLA delays. I'm less worried about getting to revenue and more interested in reaching credibility. Obviously BTD for cancer would deliver a stunning amount of credibility in an instant.

I think it is very possible that CYDY's management fails to fully capture all the potential of leronlimab for shareholders but they would have to really screw up to not capture at least 2-3 billion.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

HCLTech Achieves Remarkable Growth with Strategic Innovations

Updated Category News Views 167

HCLTech Reports Continued Growth and Strong Financial Performance HCLTech, a renowned global technology company, has once again made headlines with remarkable growth, securing its position as a leader in the technology sector. The latest results illustrate the company’s dynamic approach and ability to navigate the shifting market landscape effectively. Impressive...

Continue Reading
Understanding the P/E Ratio of Amazon.com Inc. for Investors

Updated Category News Views 218

Analyzing the P/E Ratio of Amazon.com Inc. As of now, Amazon.com Inc. (NASDAQ: AMZN) is showing a stock price of $222.42, marking a notable increase of 2.74%. This uptick over the recent month reflects a gain of 0.78%, while over the past year, the stock has appreciated by an impressive 20.42%. For long-term shareholders, this upward trend is a positive signal. However,...

Continue Reading
Matan Companies Employees Transform Lives with Service Trip

Updated Category News Views 154

Matan Companies Employees Embark on a Meaningful Journey A dedicated team of employees from Matan Companies recently returned from a week-long service trip to El Salvador, collaborating with the Building Futures Project. This nonprofit organization focuses on empowering communities in Latin America by providing essential nutrition, education, and housing support. Making a...

Continue Reading
Revman International Teams Up with Tommy Hilfiger for Home Collection

Updated Category News Views 279

Revman International Portfolio Expansion with Tommy Hilfiger Revman International, Inc. has recently announced an exciting development in their expansion efforts by entering into a licensing agreement with Tommy Hilfiger. This collaboration marks a significant step for Revman, as it involves the development, manufacturing, and distribution of a new home accessories line...

Continue Reading
Inspired Entertainment Extends Partnership with Buzz Bingo

Updated Category News Views 102

Inspired Entertainment's Partnership with Buzz Bingo Strengthens Inspired Entertainment, Inc. (NASDAQ: INSE), a key player in the gaming industry, has recently announced an important extension of its collaboration with Buzz Bingo, a major omni-channel bingo operator in the UK. This long-term agreement highlights both companies' dedication to improving the gaming...

Continue Reading